Stay updated on Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe location entry for Italy was updated from Napoli, Italy, 80131 to Naples, Italy, 80131.SummaryDifference0.0%

- Check34 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a system-wide update and does not affect study details.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check62 days agoChange DetectedThe new screenshot shows only minor UI/layout adjustments with no changes to essential study information such as eligibility criteria, enrollment, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedThe site update introduces Revision: v3.4.2, replacing the previous Revision: v3.4.1. This change is limited to versioning and does not affect the study content, eligibility criteria, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page.